SEPT7P2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.327400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.465600E-01
Normal-vs-Stage2
4.061600E-01
Normal-vs-Stage3
3.125400E-01
Normal-vs-Stage4
4.513200E-01
Stage1-vs-Stage2
2.879200E-01
Stage1-vs-Stage3
1.365650E-01
Stage1-vs-Stage4
5.224000E-01
Stage2-vs-Stage3
1.590350E-01
Stage2-vs-Stage4
6.386600E-01
Stage3-vs-Stage4
1.114440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.436600E-01
Normal-vs-AfricanAmerican
3.681200E-01
Normal-vs-Asian
3.821600E-01
Caucasian-vs-AfricanAmerican
3.820200E-01
Caucasian-vs-Asian
3.511200E-01
AfricanAmerican-vs-Asian
8.243600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.287800E-01
Normal-vs-Female
4.404000E-01
Male-vs-Female
7.534800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.135400E-01
Normal-vs-Age(41-60Yrs)
4.755800E-01
Normal-vs-Age(61-80Yrs)
4.127000E-01
Normal-vs-Age(81-100Yrs)
3.968600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.489000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.911800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.631600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.509820E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.293620E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.573000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.805000E-01
Normal-vs-Daily Drinker
4.535200E-01
Normal-vs-Weekly Drinker
4.244200E-01
Normal-vs-Occasional Drinker
4.834600E-01
Normal-vs-Social Drinker
3.282400E-01
Non Drinker-vs-Daily Drinker
2.723200E-01
Non Drinker-vs-Weekly Drinker
3.394000E-01
Non Drinker-vs-Occasional Drinker
1.350420E-01
Non Drinker-vs-Social Drinker
1.769780E-01
Daily Drinker-vs-Weekly Drinker
7.124200E-01
Daily Drinker-vs-Occasional Drinker
7.445400E-01
Daily Drinker-vs-Social Drinker
4.778800E-01
Weekly Drinker-vs-Occasional Drinker
4.792800E-01
Weekly Drinker-vs-Social Drinker
3.531600E-01
Occasional Drinker-vs-Social Drinker
6.508600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.472400E-01
Normal-vs-Grade 2
7.833800E-01
Normal-vs-Grade 3
7.857000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.185500E-02
Grade 1-vs-Grade 3
6.426000E-02
Grade 1-vs-Grade 4
4.472400E-01
Grade 2-vs-Grade 3
9.720400E-01
Grade 2-vs-Grade 4
7.833800E-01
Grade 3-vs-Grade 4
7.857000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.106000E-01
Normal-vs-NonDiabetic
4.417000E-01
Diabetic-vs-NonDiabetic
3.969400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.273200E-01
Normal-vs-NoPancreatitis
4.287400E-01
Pancreatitis-vs-NoPancreatitis
9.539000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.787600E-01
Normal-vs-N1
4.023000E-01
N0-vs-N1
1.102380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.833800E-01
Normal-vs-TP53-NonMutant
5.669800E-01
TP53-Mutant-vs-TP53-NonMutant
4.238900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
